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Abstract
Weight reduction in overweight and obese individual’s results in physiological and behavioral
changes that make the prevention of weight regain more difficult than either initial weight loss or
the prevention of weight gain. Exercise is recommended for the prevention of weight regain by
both governmental agencies and professional organizations. To date, the effectiveness of exercise
recommendations for the prevention of weight regain has not been evaluated in a properly
designed, adequately powered trial. Therefore, we will conduct a randomized trial to evaluate the
effectiveness of 3 levels of exercise on the prevention of weight regain, in initially overweight and
obese sedentary men and women. Participants will complete a 3 month weight loss intervention of
decreased energy intake (EI) and increased exercise (100 minutes/week). Participants achieving
clinically significant weight loss (≥ 5% of initial weight), will then be randomly assigned to 12
months of verified exercise at 3 levels (150, 225 or 300 minutes/week). This study will evaluate:
1) the effectiveness of 3 levels of exercise on the prevention of weight regain over 12 months
subsequent to clinically significant weight loss (≥ 5%); 2) gender differences in weight regain in
response to 3 levels of exercise; and 3) potential compensatory changes in daily physical activity
(PA) and EI on weight regain in response to 3 levels of exercise. Results of this investigation will
provide information to develop evidenced based recommendations for the level of exercise
associated with the prevention of weight regain.
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Numerous combinations of restricted energy intake (EI) and increased exercise energy
expenditure (EEEx) have shown moderate short-term (< 6 mos.) success in producing
clinically significant (≥5%) [1-6] reductions in body weight [7-10]. However, the prevalence
of overweight and obesity among US adults continues at approximately 69% [11], due in
part to the inability of individuals who lose weight to maintain weight loss [8, 12-16]. The
prevention of weight regain differs from both initial weight loss and from maintenance of
normal weight. Weight loss increases the propensity for weight regain through decreases in
sympathetic tone, leptin, insulin, and bioactive thyroid hormones, an increase in ghrelin and
changes in substrate utilization which result in altered energy balance by impacting EI and
energy expenditure [resting metabolic rate (RMR) and physical activity (PA)] [17-23].
Exercise has been recommended for the prevention of weight regain by both governmental
agencies and professional organizations including the International Association for the
Study of Obesity (IASO) [24], the Institute of Medicine (IOM) [25], and the American
College of Sports Medicine (ACSM))[26]. The US Department of Health and Human
Services (HHS) 2008 report entitled “Physical Activity Guidelines for Americans”
recommends 30 min/d of moderate PA to elicit health benefits [27]. The HHS guidelines,
although not specific to weight management have been interpreted to be sufficient for that
purpose. Support for these recommendations is tenuous and is derived from studies with
important limitations including: 1) cross-sectional, non-randomized observational designs
[2, 15, 28-33], randomization prior to weight loss: secondary analyses of exercise groups
formed at study completion [34-36], self-reported levels of exercise [28] [36, 37] [38]; and
5) failure to supervise exercise and verify level of EEEx [36-38].
Three organizations offering exercise recommendations for the prevention of weight regain
(HHS, IOM, ACSM) have highlighted the need to conduct adequately powered studies of
sufficient duration, with randomization to different levels of exercise following completion
of weight loss to address the issue of the amount of exercise required to minimize weight
regain. Therefore, we will conduct a randomized trial to evaluate the effectiveness of 3
levels of exercise on the prevention of weight regain in a sample of initially overweight and
obese sedentary men and women. Participants will complete a 3 month weight loss
intervention consisting of decreased EI and increased PA (100 min/week). Participants
achieving clinically significant weight loss (≥ 5% of initial weight), will then be randomly
assigned to 12 months of exercise at either 150, 225 or 300 min/week. This study will
evaluate: 1) the effectiveness of 3 levels of exercise on the prevention of weight regain over
12 months subsequent to clinically significant weight loss (≥5%); 2) gender differences in
weight regain in response to 3 levels of exercise; and 3) potential compensatory changes in
daily PA and EI on weight regain in response to 3 levels of exercise.
2. Materials and methods
2.1. Participants
We will recruit 287 overweight or obese adults from Lawrence and the Kansas City, Kansas
metropolitan area who will be compensated for their participation. The sample will include
at least 50% women and 20% minorities. Primary care physician (PCP) clearance will be
required for participation. The following inclusion/exclusion criteria will be used: Inclusion.
1) Age 21 to 55 years. We have restricted our sample to this age range because we believe
that behavioral interventions for weight loss may be different for individuals who are
younger or older than this proposed age range. Additionally, individuals above age 55 are
likely to have a greater numbers of medical problems and medication use that could
significantly impact the exercise protocol and outcomes. 2) BMI of ≥ 25.0 to 45.0 kg/m2.
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We have restricted our sample to this BMI range because individuals with a BMI less than
25 kg/m2 are not classified as overweight and individuals with a BMI >45.0 kg/m2 may
require more aggressive weight loss/prevention of weight regain interventions than we have
proposed (e.g., surgery, medication, etc.). 3) Clearance for participation from their PCP.
This will be obtained via a letter to the PCP that explains the research program and is
returned to the investigators. Exclusion. 1) Participation in a research project involving
weight loss or exercise in the previous 6 months, as these proximal experiences may impact
the results of this study. 2) Participation in a regular exercise program (i.e., > 500 kcal/week.
of planned activity as estimated by questionnaire [39]. 3) Not weight stable (±4.5 kg) for 3
months prior to intake as determined from an online initial eligibility questionnaire 4)
Unwilling to be randomized to 1 of 3 exercise groups subsequent to weight loss. 5) Pregnant
during the previous 6 months, lactating, or planned pregnancy in the following 15 months.
6) Serious medical risk such as type 1 diabetes, cancer or recent cardiac event (i.e., heart
attack, angioplasty,etc.). Medical risk will be determined by a health history questionnaire
and physician consent form. 7) Eating disorders as determined by a score of 20 or greater on
the Eating Attitudes Test [40]. These individuals require counseling which is outside the
scope of this study. 8) Current treatment for psychological problems, or taking psychotropic
medications. Based on our experience, individuals meeting these criteria typically are
problematic due to time conflicts with other treatments and medications which induce
weight change. Addressing psychological problems is outside the scope of this study. 9)
Taking medications known to significantly affect weight (gain or loss). 10) Adherence to
specialized diet regimes, i.e., multiple food allergies, vegetarian, macrobiotic, etc. 11) Do
not have access to grocery shopping and meal preparation (i.e. those in military, college with
cafeteria plan, etc.). Approval for this study has been obtained from the Human Subjects
Committee at the University of Kansas-Lawrence and the University of Kansas Medical
Center-Kansas City.
2.2. Randomization
Randomization subsequent to weight loss is the only appropriate study design to adequately
address our aims. Thus, only participants who achieve clinically significant weight loss (≥
5%) from baseline (-3 to 0 months) will be eligible for randomization for prevention of
weight regain. Data from our previous weight loss trials indicate that 97%-99% of
participants will meet the 5% criteria for weight loss at 3 months and we expect ~70% will
achieve ≥10% weight loss over 3 months [41-43], thus providing a range of weight loss
typical of many weight loss programs available to the public. A range of weight loss will
also allow for for exploratory analyses to evaluate the impact of the amount of weight loss
on weight regain in response to the exercise intervention. Participants will be stratified by
gender and level of weight loss (i.e., 5 - 9.9%, 10 - 14.9%, ≥ 15%) and will be sequentially
randomized in a 1:1:1 allocation to 1 of 3 exercise groups. All randomization procedures
will be completed by the project statistician. Those participants who achieve at least 5%
weight loss will then be notified on an individual basis regarding of their randomization
assignment. Participants will be instructed not to share their randomization assignment with
other participants and staff members associated with the study.
2.3. Intervention: Behavioral weight loss clinics
Sixty minute in-person behaviorally based clinics will be conducted weekly during the 3
month weight loss period (-3 to 0 months) and during the first 3 months of the prevention of
weight regain intervention. During the final 9 months of weight regain prevention, clinics
will be held twice per month using telephone conference calls. All clinics will use
behavioral strategies based on Social Cognitive Theory (SCT) to promote change in both
diet and exercise [44]. The following components of SCT will be employed: goal setting,
self-monitoring, self-efficacy, manipulation of the environment to promote behavioral
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change, and reflection on outcome expectations and outcome value. Clinic sessions will
begin with a check-in question designed to identify barriers to diet and exercise and to allow
the group to work together to identify solutions which promotes group cohesion and social
support. Weekly homework assignments are designed to increase self-efficacy for both diet
and exercise and to provide practice of behavioral skills. For example, participants will be
asked to identify items at the grocery store that meet calorie, fat, or fiber content consistent
with a healthy diet. This learning experience improves confidence in the ability to identify
food items to promote weight loss and prevent weight regain.
Clinics will be delivered by health educators trained and supervised by a co-investigator
who will assure quality control and standardization of materials by conducting weekly staff
meetings and reviewing tape recordings of clinic sessions. All clinic participants will receive
a comprehensive program notebook which includes general guidelines regarding
participation in the program, calendars and timelines for class meetings and data reporting,
lessons for each clinic meeting, and detailed instructions for both the weight loss and
prevention of weight regain diets, including appropriate recipes, handouts, worksheets, and
assignments specific to the topic for each session.
During the last 9 months of the weight regain prevention intervention group phone clinics
(conference calls) will be used instead of the traditional face-to-face clinic to reduce the
burden of time and expense to participants and to maximize compliance with the
intervention. The phone clinic (60 minute group conference call) will provide identical
content and utilize the same procedures as the face-to-face clinic, with small differences for
logistics associated with the conference call. At each phone or face-to-face clinic meeting,
participants will record their consumption of pre-packaged meals (PM’s-section 2.4),fruits
and vegetables, and minutes of physical activity (both on and off site) and receive feedback,
if needed, to improve dietary and physical activity compliance. Data on 295 participants
from our recently completed effectiveness trial comparing weight management delivered by
group phone conference vs. face-to-face (FTF) clinics suggests that weight change during
the weight loss phase (baseline to 6 months) was −13.4 ± 6.7% and −12.3 ± 7.0% for FTF
clinic and phone, respectively. Weight change during weight regain prevention (6 to 15
months) was 6.4 ± 7.0% and 6.4 ± 5.2%, for FTF clinic and phone, respectively [45].
Results from this study and an earlier study by our group [43] suggest that phone delivery
compared to FTF clinic meetings provides equivalent weight loss as well as maintenance.
Therefore we are confident in our ability to deliver effective weight gain prevention clinics
by group phone conference call as proposed for this study. An outline of clinic topics is
presented in Table 1.
2.4. Intervention: Weight loss diet (−3 to 0 months)
The weight loss and weight regain prevention diets for this study will be based on 25+ years
of experience with weight management [41-43, 46, 47]. EI will be reduced to ~1,200 to
1,500 kcal/day using a combination of commercially available prepackaged meals (PM’s),
fruits and vegetables, low calorie shakes, and non-caloric beverages. Participants will
consume a daily minimum of 2 entrees (180 to 270 kcals each), at least 5 servings of fruits
and/or vegetables, and 3 shakes (~100 kcal each). Non-caloric beverages such as diet soda,
coffee, etc. will be allowed ad libitum. When combined with a variety of fruits and
vegetables, PM’s (entrees + shakes) provide a diet with all necessary nutrients specified by
the Dietary Reference Intakes [25].
We have targeted a minimum of 5% weight reduction from baseline to 3 months; an amount
of weight loss which is known to produce clinically significant reductions in risk for chronic
diseases such as diabetes, heart disease, hypertension, and others [1-4]. In previous
investigations by our group using a similar diet, weight loss at 3 months averaged 12.5%
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(range (11.1-13.7%) [41, 43, 47]. Participants reaching a BMI of 22 kg/m2 during weight
loss will be transitioned to the prevention of weight regain diet described below; however, in
our experience, this is an infrequent occurrence. Individuals achieving < 5% weight loss at 3
months will not be eligible for randomization and will be referred to our ongoing weight
management programs or to other community resources for weight management.
2.5. Intervention: Prevention of weight regain diet (0 - 12 months)
We recognize there are numerous approaches to the prescription of EI for the prevention of
weight regain. We were influenced by the IOM dietary recommendations for weight regain
prevention [25], over 25 years experience with research trials and clinical weight
management, and the desire to evaluate a practical and generalizable approach. Therefore,
following weight loss we will recommend a daily EI of estimated RMR * 1.2 to account for
activities of daily living [48]. This EI recommendation theoretically results in a negative
energy balance in all groups when EEEx is considered. However, we anticipate
compensatory changes in components of energy balance such as increased EI and/or
decreased daily PA (both of which are measured in this trial) as the literature indicates most
individuals regain weight subsequent to weight loss [8, 12-16]. Thus, we believe our
approach will maximize the potential to prevent weight regain and provides a reasonable
compromise between scientific rigor, practicality, and generalizability.
During the weight regain prevention intervention, participants will receive a meal plan with
suggested servings of grains, proteins, fruits, vegetables, dairy, and fats, based on their
energy requirements and the USDA/HHS Dietary Guidelines for Americans 2010 [34].
Participants will be encouraged (not required) to continue consuming a minimum of 14
PM’s (entrees or shakes) and a minimum of 35 servings of fruits and vegetables per week.
They will be provided with a list of low calorie PM’s and shakes available at local
supermarkets or may purchase the PM’s and shakes provided during the weight loss phase
from the study coordinator.
2.6. Intervention: Exercise during weight loss (-3 to 0 mos.)
During weight loss we will use a verified, progressive exercise protocol that we have used in
numerous previous investigations [41-43, 49]. Exercise will progress from 10 minutes/day, 5
days/week, 65% age-predicted maximal heart rate (HRmax = 220 - age in years) to the goal
of 20 minutes/day, 5/days/week, 70% HRmax (100 minutes/week) at week 7 and remain at
this level through study week 12. The intensity and duration of both on-site supervised and
non-supervised exercise (walking or running) sessions will be verified by a HR monitor.
Participants will be required to complete a minimum of 3 of the 5 sessions under supervision
in one of our 3 exercise facilities (2 in Lawrence, 1 in Kansas City). One of the supervised
exercise sessions may be completed prior to/following the clinic meeting since the facilities
for exercise and clinics are located in the same building. Each facility contains state-of-the-
art exercise equipment, televisions and provides an environment similar to a modern
commercial exercise center. Treadmill walking will be the primary mode of supervised on-
site exercise; however, we will permit alternative modes of aerobic exercise (elliptical, bike,
etc.) during 1 exercise session/week. Allowing alternative exercise modes provides relief
from the routine for some participants and may help prevent overuse injuries.
2.7. Intervention: Exercise during prevention of weight regain (0 to 12 months)
Subsequent to 3 months of weight loss, participants will be randomized to exercise groups of
150, 225 or 300 min/week. Exercise will be progressed from 100 min/week at 70% HRmax
at the end of weight loss (week 12) to the prescribed goals over weeks 13-17 of weight
regain prevention and remain at goal for the duration of the trial (weeks 18-60) (Table 2).
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Consistent with the protocol for exercise during weight loss (-3 to 0 months) participants
will be asked to complete a total of 5 exercise sessions/week and will be required to
complete a minimum of 3 sessions under supervision in our exercise facilities. As during
weight loss, treadmill walking will be the primary mode of on-site exercise; however, we
will permit alternative modes of aerobic exercise (elliptical, bike, etc.) during 1 exercise
session/week. We realize that these are demanding exercise protocols; however, they
represent national recommendations for the level of exercise associated with the prevention
of weight regain. Our group, as well as others, have demonstrated the ability of previously
sedentary, overweight and obese individuals to adhere to these levels of exercise (185-300
min/wk) in trials of 10 [50], 12 [38] and 16 mo. [51] duration.
2.8. Assessment of exercise compliance: Heart rate monitoring
The frequency, intensity and duration of both supervised and unsupervised exercise sessions
will be documented using downloadable HR monitors (Polar RS 400, Polar Electro Inc.,
Woodbury, NY) which are capable of collecting and storing 99 hours of HR data collected
over 1-minute epochs. A valid exercise session will be defined as an average HR ± 4 beats/
min of target HR for the prescribed exercise duration. Participants not completing a valid
exercise session will be counseled to meet both the intensity and duration prescriptions.
Each exercise session will be preceded by a brief (5 minutes) warm up. Participants will
then be instructed to increase their exercise intensity to reach their prescribed target HR
(70% of maximal HR ± 4 beats/minute) prior to starting the HR monitor and to remain at the
target intensity for the duration of each exercise session. During all supervised exercise
sessions trained research staff will monitor participants exercise HR to insure that it remains
at target. Prior to each supervised exercise session (minimum of 3 sessions/week) research
staff will download HR data from all unsupervised exercise sessions completed since the last
visit to the exercise laboratory using the Polar HR Software. Research staff will review
intensity and duration of the unsupervised exercise sessions and provide feedback to the
participant.
2.9. Assessment of exercise compliance: Aerobic fitness
As a secondary measure of compliance with the exercise protocol we will assesses aerobic
fitness using a sub-maximal treadmill test at −3, 0, 6 and 12 months. The treadmill will be
initially set a 3 m.p.h., 0% grade. Speed will remain constant and grade will be increased 1%
each minute until the participant reaches either 75% age predicted HR max (participants not
on beta blockers) or a rating of perceived exertion (RPE) of 16 on the Borg Scale (REF)
(participants taking beta blockers). Heart rate (3-lead electrocardiogram: Marquette
Electronics, Milwaukee, WI, USA) and perceived exertion will be assessed during the last
15 seconds of each stage. Aerobic fitness will be defined as the metabolic equivalent (MET)
level estimated from treadmill speed and grade achieved during the last stage completed
after achieving either the HR or RPE criteria.
2.10. Assessment of EEEx
Variation in body weight results in inter-individual differences in EEEx when performing
weight bearing exercise of the same duration [51]. Therefore, to document the actual level of
energy expenditure associated with each of the 3 exercise prescriptions (150, 225 and 300
minutes/week) over the course of the weight regain prevention trial we will assess EEEx in
all participants at months 2, 7 and 12 to document the level of EEEx associated with each of
the 3 exercise prescriptions. EEEx will be assessed by indirect calorimetry (ParvoMedics
TrueOne2400, ParvoMedics Inc., Sandy, UT) during treadmill exercise over a 15 minute
interval (1-minute epochs) at 75% age-predicted HRmax (± 4 beats/minute).The average
EEEx (kcal/minute) over the 15 minute interval will be calculated from measured oxygen
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consumption and carbon dioxide production using the Weir equation [23]. We have not
proposed measures of EEEx during weight loss since the exercise prescription is
progressive, and will be confounded by continuous changes in body weight induced by the
weight loss protocol. In addition, our primary aim is to evaluate the effect of EEEx on the
prevention of weight regain, not on weight loss.
2.9. Behavioral strategies for increasing exercise compliance
We will employ behavioral strategies to increase exercise compliance that are based on well-
accepted theoretical models including SCT, Problem Solving Theory, Relapse Prevention
and Stages of Motivational Readiness for change, to provide participants the necessary skills
to adopt and maintain the targeted exercise behaviors [52-56]. Specific strategies will
include, but not be limited to, self-monitoring, goal setting, problem solving, mastery skills,
social support, and relapse prevention. In the context of this investigation, goals for the level
of exercise will be predetermined by study design, with strategies implemented by exercise
facility staff to reinforce the attainment of these prescribed goals.
To facilitate adoption of prescribed doses of exercise the prescription will be progressed
slowly (Table 3) to provide mastery experiences and improve self-efficacy as participants
move from a sedentary state to 100 and then to, 150, 225 or 300 min/week, during the first 3
to 6 months of the intervention. Participants will also be provided access to an exercise
facility that is easily accessible (on-site free parking), temperature controlled, and with state-
of-the-art equipment and entertainment packages. In addition, during the first 6 months of
the study we will provide the opportunity for participants to complete one of their
supervised exercise sessions prior to/following their regular face-to-face clinic meetings
which will reduce participant burden and may improve exercise compliance.
2.12. Strategies for participant retention
We will obtain participant contact information to include name, address, telephone numbers,
and email, as well as contact information for at least two family members or close friends
who will know the location of the participant throughout the duration of the intervention.
Participants who miss more than 3 consecutive scheduled on-site exercise sessions will be
contacted by study staff by phone, text or email. After a maximum of 3 unsuccessful contact
attempts, no further attempts will be made during the intervention period. However,
participants as well as family members will be contacted to encourage completion of the
end-study outcome assessments. Staff training will focus on relationship building between
participants and the intervention team. Weekly project meetings with the principal
investigator and the intervention team will problem solve any participant retention issues
that may arise. We will also mail birthday cards, holiday cards, and program reminders to all
participants. Undeliverable mailings, returned with a forwarding address, will be used to
track participants who were potentially lost to follow-up. We will use behavioral contracts at
multiple time points during recruitment, assessment, and after randomization to support our
retention efforts and to determine the understanding of participants regarding the
requirements for study participation. These strategies resulted in a loss to follow-up of 22%
in our recently completed trial comparing the effectiveness of phone with face-to-face
behavioral clinics for weight management [45]
2.13. Outcome assessments
All outcome assessments will be completed by trained research staff in the Center for
Physical Activity and Weight Management, Energy Balance Laboratories (EBL) at either
The University of Kansas-Lawrence or the University of Kansas Medical Center, Kansas
City, Kansas. Research staff performing outcome assessments will be separate from those
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who supervise exercise or conduct behavioral clinics and will be blinded to study condition.
The schedule for outcome assessments is presented in Table 3.
2.13.1. Anthropometrics—Body weight, height and waist circumference will be
recorded at −3, 0, 3, 6, 9 and 12 months. Weight will be obtained using a digital scale
accurate to ± 0.1 kg (Befour Inc. Model #PS6600, Saukville, WI). Participants will report to
the EBL between the hours of 6 and 10 AM, after an overnight fast, and be weighted prior to
breakfast after attempting to void wearing a standard hospital gown. Height will be
measured using a stadiometer (Model PE-WM-60-84, Perspective Enterprises, Portage, MI)
and BMI (kg/m2) will be calculated. Waist circumference will be assessed using procedures
described by Lohman et al. [41]. We will obtain 2 measurements per site within 2 cm.
2.13.2. Energy intake—Energy intake will be assessed by 3-day food records (2 week
days/1 weekend day) at −3, 0, 3, 6, 9 and 12 months prior to reporting to the laboratory for
anthropometric assessments. Participants will be given verbal instructions and provided with
written instructions titled “How to complete your food record” to improve record keeping.
Food records will be reviewed by a registered dietitian during the laboratory visit to clarify
any ambiguities. Data from the 3-day food records will be entered in the Nutrition Data
System for Research (NDSR, version 2012, University of Minnesota) for calculation of
energy and macronutrient content.
2.13.3 Dietary staff training and quality control—All staff will complete
standardized training for 24-hour recalls and NDS-R coding, prior to the beginning of data
collection, with refresher sessions every 2 months, thereafter. After initial training, all
dietary assessment staff will be required to complete ten 24-hour recalls obtained from non-
study subjects and enter this data directly into NDS-R. The recalls will be evaluated
according to a published dietary recall documentation checklist [51]. An error rate of less
than 5% on this checklist and on NDS-R coding will be required before interviewers will be
allowed to collect and process dietary recall data. During the study, all dietary recalls will be
evaluated by our study dietician using the recall documentation checklist before entry into
the study database. Any recall with greater than 5% error will be eliminated and another
recall obtained. Study staff demonstrating an error rate of 5% or greater for either energy
intake or macronutrient composition, will be required to obtain further training and repeat
assessment of accuracy described previously. Staff not meeting our criteria for accuracy at
any time during the study following 3 attempts will not be permitted to collect or process
dietary data.
2.13.4. Physical activity by accelerometry—To determine day-to-day and within-day
variation in PA (i.e., compare exercise to non-exercise days, exercise time vs. non-exercise
time), as well as to estimate the time spent in a range of PA intensity levels (moderate,
vigorous), participants will wear an ActiGraph Model GT3+ (ActiGraph, LLC, Pensacola,
FL) portable accelerometer for 7 consecutive days at −3, 0, 6, and 12 months on a belt over
the non-dominant hip. The data collection interval will be set at one min with a minimum of
12 hours constituting a valid monitored day. We will apply the intensity cut-points used in
the National Health and Nutrition Examination Survey as described by Troiano et al [57];
moderate (> 3 METS= >2020 counts/min), vigorous (>6 METS= >5999 counts/min). We
have a custom SAS program to complete these analyses.
2.13.5. Process Measures: Diet/exercise—Process data will be collected to assess the
fidelity of both the dietary and exercise components of the intervention. Diet: Health
educators will track the number of PM’s consumed, fruit and vegetable intake, attendance at
clinic meetings, and the number of reported midweek checks completed. Exercise: Staff will
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track the number of both supervised and unsupervised sessions completed and the intensity
and duration of all completed sessions.
2.13.6. Medical management—Signed clearance from a licensed physician will be
required prior to participation. Additionally, all individuals must qualify based on their
health history reported at baseline.
2.14. Analysis plan and statistical power
2.14.1. Analysis plan aims 1 and 2—1) To assess the effectiveness of 3 exercise
recommendations on the prevention of weight regain over 12 mos. subsequent to clinically
significant weight loss (≥ 5%); and 2) To evaluate gender differences in weight regain in
response to 3 exercise recommendations. To evaluate the significance of the main effects
(treatment and/or gender) on weight change (month 12 - month 0) we will use a 2-factor
analysis of variance to compare weight change during the weight regain prevention
intervention while including the treatment X gender interaction term in the initial model. If
the interaction term is not significant, as expected, it will be excluded and the model will
include only main effects for treatment and gender. If Treatment effect is significant
(p<0.05), we will conduct pairwise comparisons between the 3 treatment groups using a type
I error rate of 0.0167 for each pairwise comparison. The test of the main effect of gender
involves only one comparison and thus will be evaluated with a type 1 error rate of 0.05. We
will then use linear mixed models, assuming an autoregressive correlation structure over
time, to model weight at 3, 6, 9 and 12 months post randomization, using weight at time 0 as
a covariate. We will include main effects (treatment, gender, time) and also examine
potential main effect by time interactions. This analysis will allow us to determine the time
course of change, evaluate when treatment differences occur, and determine if treatment
differences continue to increase or attenuate over time. We will also determine at what time
point gender differences occur and whether or not differences increase or attenuate over
time.
We will determine if proportion of participants lost to follow-up differs by treatment and/or
gender and compare demographic characteristics between those lost to follow-up and
completers. If the proportion lost to follow-up differs across treatment groups, we will
examine demographic characteristics (gender, age, amount of weight loss) between lost to
follow-up and completers) then determine if there are between group differences in those
characteristics. If missing data are related to treatment and/or demographic characteristics,
missing data will be imputed with model based multiple imputation methods, if not,
traditional multiple imputation will be used. Based upon our previous effectiveness weight
management trial, we expect ≤25% of randomized participants will be lost to follow-up [45].
2.14.2. Analysis plan aim 3: To assess potential compensatory changes in
daily PA and EI on weight regain in response to 3 exercise recommendations
—We will compare change in daily PA and EI in a similar manner as described for aims 1
and 2. We will first conduct 2-factor (treatment/gender) analysis of variance to examine
changes in PA and EI over the duration of the prevention of weight regain intervention (0 to
12 months). We will then construct linear mixed models to evaluate the impact of PA and EI
on weight regain while controlling for both treatment group and gender.
2.14.3 Potential exploratory analyses—Data collected in this study will provide the
opportunity for a number of interesting exploratory analyses which will include by not be
limited to: Dose/response: A preliminary assessment of the dose-response association
between total EEEx and weight regain will be obtained by calculating the actual EEEx
during the weight regain prevention intervention and using this as a covariate in a linear
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mixed model assessing weight change while controlling for gender. Efficacy: We will
conduct a “per protocol/pseudo-efficacy” analysis for weight regain including only
participants who complete the study and are at least 80% compliant with exercise
recommendations. This analysis will be performed as described for our primary aims 1 and
2. Amount of weight loss: The amount of weight loss may impact weight regain. We will
include the amount of weight loss as a covariate in our longitudinal linear mixed models to
examine its impact on weight regain while controlling for treatment, gender and time.
Energy intake/diet composition: To determine if energy intake and/or diet composition (%
fat, protein, carbohydrate) impact weight regain we will include these variables in a
longitudinal model controlling for treatment, gender, time, and initial weight loss, if
significant. All statistical analyses will be completed with SAS version 9.2 or higher.
2.14.4. Power and sample size—Table 5 details the hypothesized amount of weight
regain in each of the 3 exercise groups (100, 225, 300 minutes/week) by gender during
weight regain prevention (0 to 12 months) based on the results from our recently completed
trial comparing the effectiveness of weight loss/regain between behavioral clinics delivered
face-to-face vs. phone conference call which included unsupervised PA [45]. Using these
assumptions we propose to randomize 86 participants who lose ≥5% of initial weight (43
men and 43 women) to each of the 3 groups following our 3 month weight loss intervention.
This provides a total sample of 258 participants (129 males; 129 females). To be
conservative, we estimate a total attrition during weight loss (drop out + failure to achieve
5% weight loss) of 10%, thus we will enroll a total of 287 participants at baseline (-3
months). Baseline enrollment has not been inflated for potential loss to follow-up as we will
use intent-to-treat as our primary analysis using imputed data for those lost to follow-up as
described previously (2.14.1). Using a 2-factor analysis of variance on weight regain with a
type 1 error rate of 5% the proposed sample size will provide 99% power for overall trend
across the 3 treatment groups, 98% power for test of gender and 5% power for interaction,
assuming a common standard deviation of 6.0kg for weight regain from baseline to 12
months. Based on the hypothesized gender differences (Table 4) we do not expect a
statistically or clinically significant treatment by gender interaction, thus the limited power.
If, as expected, the interaction term is not significant, it will be excluded from the model
which will then include main effects for treatment and gender. Adjusting the type 1 error
rate for 3 pairwise comparisons (0.0167) we will have over 80% power for comparisons of
weight regain between the 100 vs. 225 minutes/week and 225 vs. 300 min/week groups, and
99% power for a pairwise comparison of the 100 vs. 300 minute/week groups. Thus, we
have adequate statistical power to evaluate each main effect and all potential pairwise
comparisons across the 3 treatment groups.
3.0. Discussion
The prevention of weight regain following weight loss is problematic. Approximately 50%
of individuals who initially lose weight will regain more than 45-75% of the weight lost
within 12 to 30 months from the end of treatment [8, 12-16]. This trial is designed and
adequately powered to evaluate the level of exercise associated with the prevention of
weight regain subsequent to clinically significant weight loss. Important design features of
this study include: randomization subsequent to weight loss to assure equal distribution of
physiologic changes associated with weight loss that may impact weight regain across
exercise groups; verification of completion of all exercise sessions and the assessment and
documentation of EEEx; adequate statistical power to evaluate gender differences in the
response to 3 levels of exercise; and a long duration intervention (12 months) with
assessment of primary outcomes at 3 month intervals to examine the time course of weight
change. The results of this trial will provide a more complete understanding of the weight
change response to exercise following weight loss in both men and women and will provide
Donnelly et al. Page 10













preliminary information regarding compensatory changes in energy intake and daily PA that
may affect this response. This information will be important for the development of
evidenced based recommendations for the level of EEEx associated with the prevention of
weight regain in men and women.
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Intro Program Introduction: Intro to diet, meeting
format, group members
Diet/Exercise/Behavior
1 Diet Review and Benefits of Exercise Diet/Exercise
2 Goal Setting, Realistic Weight Loss Goals,
Personal Reasons for Weight Loss and setting
goals for Exercise
Behavior
3 Increasing Fruits and Vegetables/Benefits of
Fiber
Diet
4 Exercise 101 (clothing, distractions, adverse
weather, etc.)
Exercise
5 Self-Monitoring of diet and exercise behaviors Diet/Exercise
6 Know Your Health Numbers (effects of nutrient
dense diet and PA on metabolic risk factors)
Diet/Exercise
7 Reading Food Labels – Your Tool to Healthy
Eating
Diet
8 Warm-up/Cool-down and Injury prevention Exercise
9 Making Exercise Part of Your Routine (i.e.,
planning, adherence, and coping with sore
muscles)
Exercise
10 F.I.T (Frequency, Intensity, and Duration) Exercise
11 Healthy cooking and Meal Planning Diet






13 Review of Program Goals/Objectives
Exercise Adherence (importance of attendance
and coping with life events)
Behavior/Exercise
14 Intuitive eating Diet/Behavior
15 Grocery Shopping Diet
16 Portion distortion Diet
17 Maintaining motivation for diet and exercise Diet/exercise
18 Exercising on vacation Exercise
19 Environmental Control Behavior
20 Eating on the Go / Hidden calories Diet
21 Resistance Training Exercise
22 Emotional Eating Diet/Behavior
23 Energy Density Diet
24 Circuit Training (With demo) Exercise
Weight regain prevention Month 3-12
(Phone)
26 Doing exercise on your own Exercise
28 Social Relationships and Social Situations Behavior
30 Benefits of Exercise (i.e., general physiology and
diseases)
Exercise
32 Mental Traps, Cognitive Attributions &
Reframing
Behavior
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34 Myth Busters- Exercise Exercise
36 Coping with Cravings &Stress Related Eating
(Urge surfing)
Diet/Behavior
38 Increasing Lifestyle Activities and Decreasing
Sedentary Time
Exercise
40 Mindful Eating Diet
42 Myth Busters - Diet and fad diets Diet
44 Exercise Variety Exercise
46 Evidence Based Advice on Eating for Long-term
Weight Control
Diet/Behavior
48 Healthy Breakfast Tips/ Picking Healthy Snacks Diet
50 Energy expenditure and metabolism Exercise
52 Psychosocial Barriers to Weight Maintenance &
Self and Body Image
Behavior
54 Accountability and Self-Monitoring Revisited -
Looking towards the future
Behavior
56 Meal Planning Revisited Diet
58 Successful Weight Management Tips & Strategies/Relapse
Prevention Revisited
Diet/Exercise/Behavior
60 Reflecting and Re-Motivating and Reassessing Goals Behavior
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Table 2
Exercise progression (minutes/week) during the prevention of weight regain (weeks 13-60) for the 3 exercise
groups
Treatment Groups
Study Week 150 min/wk. 225 min/wk. 300 min/wk.
13 125 125 175
14 130 135 200
15 135 150 225
16 140 175 250
17 145 200 275
18-60 150 225 300








































DXA X X X X
Energy Intake
(3-day food records)
X X X X X X
Fitness X X X X
Physical Activity
(Accelerometer)
X X X X
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Table 4









Male change (kg) 6.4 3.5 0.5
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